Experiment 1094810
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | CREECH,RH: STANLEY,K: VOGL,SE: ETTINGER,DS: BONOMI,PD: SALAZAR,O:. (1982). PHASE II STUDY OF CISPLATIN,MAYTANSINE,AND CHLOROZOTOCIN IN SMALL CELL LUNG CARCINOMA (EST 2578).. 66() |
| Amount utilized | |
| Compound isolated | |
| Disease | A PHASE II STUDY OF MAYTANSINE IS REPORTED IN 25 PATIENTS WITH SMALL CELL LUNG CARCINOMA REFRACTORY TO STANDARD CHEMOTHERAPY. OF THE 19 EVALUABLE PATIENTS NO PARTIAL RESPONSE WAS OBSERVED. ONE THIRD OF THE PATIENTS EXPERIENCED MODERATE OR SEVERE NEUROLOGIC TOXICITY. DOSING WAS DAILY FOR 21 DAYS. |
| Dose amount | 1.5 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |